Suzhou Basecare Medical Corporation Limited (Basecare Medical) submitted its Monthly Return to Hong Kong Exchanges and Clearing on 06 May 2026, covering the period ended 30 April 2026. The filing confirms that the company’s share structure remained static throughout the month.

Total issued share capital stood at 273.53 million shares with a par value of RMB 1 each. The composition was unchanged from the previous month: • H shares listed in Hong Kong: 82.71 million (30.25 %) • Domestic shares: 183.18 million (66.97 %) • Unlisted foreign shares: 7.63 million (2.79 %)

No new shares were issued, cancelled, or repurchased, and treasury shares remained at zero. Basecare Medical also reported no outstanding share options, warrants, convertibles, or other contingent equity arrangements.

The company confirmed compliance with the Main Board’s minimum public-float requirement—maintaining at least 25 % of its H-share class in public hands. Additionally, neither the company nor its subsidiaries have repurchased any listed securities since 01 January 2026.

The stable capital structure and absence of equity-linked instruments indicate that Basecare Medical’s share base and investor exposure were unchanged during the reporting month.